FINWIRES · TerminalLIVE
FINWIRES

Johnson & Johnson Highlights Pipeline Catalysts, Reaffirms Growth Outlook After Q1 Beat, RBC Says

By

Johnson & Johnson (JNJ) outlined strong pipeline catalysts across Innovative Medicine and MedTech, reinforcing its long-term double-digit growth outlook after delivering a Q1 2026 earnings beat and raising full-year guidance, with its growth acceleration thesis remaining intact, RBC Capital said in a Tuesday note.

RBC highlighted strength in key growth drivers including Tremfya, Carvykti, and newly launched Icotyde, which management said could become one of its largest future products, while MedTech growth remains steady with expectations to reach high single-digit growth by the end of the decade.

Management modestly raised 2026 guidance to about 6.1% operational sales growth and $11.55 in adjusted earnings per share at the midpoint, while also reporting an estimated around 2% sales beat and 1% EPS beat, according to the report.

The company highlighted pipeline opportunities across oncology, cardiovascular, and bladder cancer therapies, along with device innovation, supporting mid- to high-single-digit growth acceleration through the end of the decade, RBC added.

RBC maintained its outperform rating on the stock and raised its price target to $265 from $255.

Shares of Johnson & Johnson were down 0.7% in Wednesday trading.

Price: $238.44, Change: $-1.66, Percent Change: -0.69%

Related Articles

Wire

GitLab Broadens Google Cloud Collaboration to Support AI Agents

GitLab (GTLB) said late Tuesday it expanded its collaboration with Alphabet's (GOOGL, GOOG) Google Cloud, allowing customers to use Google's Vertex AI models to power the GitLab Duo Agent Platform.The integration lets joint customers call Google's AI models directly inside GitLab, with that usage counting toward their existing Google Cloud spending commitments. GitLab said the move pairs Google's model performance with GitLab's built-in security, compliance and audit controls.GitLab shares rose 6.5% in after-hours trading, and Alphabet was little changed.

$GOOG$GOOGL$GTLB
Wire

TeraWulf Preliminary Q1 Revenue Misses Estimates; $800 Million Stock Offering Planned

TeraWulf (WULF) reported preliminary Q1 revenue late Tuesday of $30 million to $35 million and adjusted EBITDA of breakeven to $3 million.Analysts polled by FactSet expect revenue of $37.5 million and EBITDA of $7.6 million.Separately, the company announced an $800 million offering of common shares with underwriters granted a 30-day option to buy up to an additional $120 million in stock.Net proceeds will be used in part to finance a portion of the construction of a data center at its site in Hawesville, Kentucky.TeraWulf shares fell 7.3% in after-hours trading.

$WULF
Wire

Equity Bancshares Q1 Core EPS, Revenue Rise; Shares Fall After Hours

Equity Bancshares (EQBK) reported Q1 core earnings late Tuesday of $1.32 per diluted share, up from $0.90 a year earlier.Analysts polled by FactSet expected $1.16.Revenue in the three months ended March 31, expressed as the sum of net interest income and total noninterest income, rose to $83.2 million from $60.6 million a year earlier.Four analysts surveyed by FactSet expected $82.7 million.The company's shares fell 4.1% in after-hours trading.

$EQBK